0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Pancreatic Extracts in the Treatment of Psoriasis:  An Evaluation of Entozyme and Lipan

EUGENE M. FARBER, M.D.; HAROLD M. SCHNEIDMAN, M.D.
AMA Arch Derm. 1957;76(2):239-240. doi:10.1001/archderm.1957.01550200083017.
Text Size: A A A
Published online

In the past five years, there has been an increased interest in the use of pancreatic extracts in the treatment of patients with psoriasis. The advocates of pancreatic therapy have claimed improvement and remissions in as high as 77% of the patients treated.1-3

Pancreatin N. F. is a pancreatic extract containing three enzymes—amylase, lipase and trypsin— which act in the intestinal tract on carbohydrates, fats, and proteins respectively. The two products containing pancreatin which were commercially available at the beginning of this investigation were Entozyme and Lipan. In addition to containing pancreatin, Entozyme contains pepsin and bile salts, while Lipan contains vitamin Bi and vitamin D. Since the effectiveness of both Entozyme and Lipan was attributed to the action of pancreatin, these drugs were considered to be essentially the same.

The rationale for the use of pancreatin has rested on the premise

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();